Meeting the Demand for New Antibiotics
Nabriva Therapeutics is committed to researching and developing new antibiotics to treat infectious diseases. Our dedicated team includes people with extensive science and industry experience and a shared passion for addressing the increasingly urgent problem of bacterial resistance worldwide.
Nabriva is a clinical-stage biopharmaceutical company with locations in the
United States (King of Prussia, PA), Austria (Vienna), and Ireland (Dublin), home of our corporate headquarters.